325 related articles for article (PubMed ID: 27193823)
1. Platelet-derived growth factor receptor/platelet-derived growth factor (PDGFR/PDGF) system is a prognostic and treatment response biomarker with multifarious therapeutic targets in cancers.
Appiah-Kubi K; Wang Y; Qian H; Wu M; Yao X; Wu Y; Chen Y
Tumour Biol; 2016 Aug; 37(8):10053-66. PubMed ID: 27193823
[TBL] [Abstract][Full Text] [Related]
2. The clinical significance of platelet-derived growth factors (PDGFs) and their receptors (PDGFRs) in gastric cancer: A systematic review and meta-analysis.
Qian H; Appiah-Kubi K; Wang Y; Wu M; Tao Y; Wu Y; Chen Y
Crit Rev Oncol Hematol; 2018 Jul; 127():15-28. PubMed ID: 29891108
[TBL] [Abstract][Full Text] [Related]
3. Increased sensitivity to the platelet-derived growth factor (PDGF) receptor inhibitor STI571 in chemoresistant glioma cells is associated with enhanced PDGF-BB-mediated signaling and STI571-induced Akt inactivation.
Servidei T; Riccardi A; Sanguinetti M; Dominici C; Riccardi R
J Cell Physiol; 2006 Jul; 208(1):220-8. PubMed ID: 16575905
[TBL] [Abstract][Full Text] [Related]
4. PDGFs and their receptors.
Kazlauskas A
Gene; 2017 May; 614():1-7. PubMed ID: 28267575
[TBL] [Abstract][Full Text] [Related]
5. The platelet-derived growth factors (PDGFs) and their receptors (PDGFRs) are major players in oncogenesis, drug resistance, and attractive oncologic targets in cancer.
Wang Y; Appiah-Kubi K; Wu M; Yao X; Qian H; Wu Y; Chen Y
Growth Factors; 2016 Feb; 34(1-2):64-71. PubMed ID: 27170215
[TBL] [Abstract][Full Text] [Related]
6. Functions of paracrine PDGF signaling in the proangiogenic tumor stroma revealed by pharmacological targeting.
Pietras K; Pahler J; Bergers G; Hanahan D
PLoS Med; 2008 Jan; 5(1):e19. PubMed ID: 18232728
[TBL] [Abstract][Full Text] [Related]
7. Platelet-derived growth factor (PDGF) autocrine signaling regulates survival and mitogenic pathways in glioblastoma cells: evidence that the novel PDGF-C and PDGF-D ligands may play a role in the development of brain tumors.
Lokker NA; Sullivan CM; Hollenbach SJ; Israel MA; Giese NA
Cancer Res; 2002 Jul; 62(13):3729-35. PubMed ID: 12097282
[TBL] [Abstract][Full Text] [Related]
8. Inhibition of platelet-derived growth factor actions in the embryonic testis influences normal cord development and morphology.
Uzumcu M; Dirks KA; Skinner MK
Biol Reprod; 2002 Mar; 66(3):745-53. PubMed ID: 11870082
[TBL] [Abstract][Full Text] [Related]
9. The role of small molecule platelet-derived growth factor receptor (PDGFR) inhibitors in the treatment of neoplastic disorders.
Roskoski R
Pharmacol Res; 2018 Mar; 129():65-83. PubMed ID: 29408302
[TBL] [Abstract][Full Text] [Related]
10. PDGF receptors as targets in tumor treatment.
Ostman A; Heldin CH
Adv Cancer Res; 2007; 97():247-74. PubMed ID: 17419949
[TBL] [Abstract][Full Text] [Related]
11. Platelet-derived growth factors and their receptors: structural and functional perspectives.
Chen PH; Chen X; He X
Biochim Biophys Acta; 2013 Oct; 1834(10):2176-86. PubMed ID: 23137658
[TBL] [Abstract][Full Text] [Related]
12. Beta-platelet-derived growth factor receptor mediates motility and growth of Ewing's sarcoma cells.
Uren A; Merchant MS; Sun CJ; Vitolo MI; Sun Y; Tsokos M; Illei PB; Ladanyi M; Passaniti A; Mackall C; Toretsky JA
Oncogene; 2003 Apr; 22(15):2334-42. PubMed ID: 12700668
[TBL] [Abstract][Full Text] [Related]
13. The PDGF/PDGFR pathway as a drug target.
Papadopoulos N; Lennartsson J
Mol Aspects Med; 2018 Aug; 62():75-88. PubMed ID: 29137923
[TBL] [Abstract][Full Text] [Related]
14. Identification of a domain within the carboxyl-terminal region of the beta platelet-derived growth factor (PDGF) receptor that mediates the high transforming activity of PDGF.
Uren A; Yu JC; Li W; Chung IY; Mahadevan D; Pierce JH; Heidaran MA
J Biol Chem; 1996 May; 271(19):11051-4. PubMed ID: 8626645
[TBL] [Abstract][Full Text] [Related]
15. Platelet-derived growth factors and receptors in Canine Lymphoma.
Aricò A; Guadagnin E; Ferraresso S; Gelain ME; Iussich S; Rütgen BC; Mazzariol S; Marconato L; Aresu L
J Comp Pathol; 2014 Nov; 151(4):322-8. PubMed ID: 25172054
[TBL] [Abstract][Full Text] [Related]
16. New insights about the PDGF/PDGFR signaling pathway as a promising target to develop cancer therapeutic strategies.
Pandey P; Khan F; Upadhyay TK; Seungjoon M; Park MN; Kim B
Biomed Pharmacother; 2023 May; 161():114491. PubMed ID: 37002577
[TBL] [Abstract][Full Text] [Related]
17. [Function, molecular structure and gene expression regulation of Platelet-derived growth factor].
Kaji K
Nihon Rinsho; 1992 Aug; 50(8):1902-9. PubMed ID: 1433982
[TBL] [Abstract][Full Text] [Related]
18. Use of multitarget tyrosine kinase inhibitors to attenuate platelet-derived growth factor signalling in lung disease.
Kanaan R; Strange C
Eur Respir Rev; 2017 Dec; 26(146):. PubMed ID: 29070579
[TBL] [Abstract][Full Text] [Related]
19. Expression and prognostic significance of platelet-derived growth factor and its receptors in epithelial ovarian neoplasms.
Henriksen R; Funa K; Wilander E; Bäckström T; Ridderheim M; Oberg K
Cancer Res; 1993 Oct; 53(19):4550-4. PubMed ID: 8402626
[TBL] [Abstract][Full Text] [Related]
20. Targeting the PDGF/PDGFR signaling pathway for cancer therapy: A review.
Zou X; Tang XY; Qu ZY; Sun ZW; Ji CF; Li YJ; Guo SD
Int J Biol Macromol; 2022 Mar; 202():539-557. PubMed ID: 35074329
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
